Report copyright - Q2 FY18 Investor Presentation - Eris Lifesciences · 2018-08-21 · Our business segments H1 FY 2018 : Revenue comparison of Eris with IPM 2,682 2,856 1,412 1,615 H1 FY 17 H1 FY 18
Please pass captcha verification before submit form
Please pass captcha verification before submit form